References
1. Wong CY, Helm MA, Kalb RE, Helm TN, Zeitouni NC. The presentation,
pathology, and current management strategies of cutaneous metastasis.N Am J Med Sci . 2013;5(9):499-504. doi:10.4103/1947-2714.118918.
2. Spratt DE, Gordon Spratt EA, Wu S, et al. Efficacy of skin-directed
therapy for cutaneous metastases from advanced cancer: a meta-analysis.J Clin Oncol . 2014;32(28):3144-3155. doi:10.1200/JCO.2014.55.4634.
3. Oike T, Adachi A, Shirai K, Ohno T. Unresectable cutaneous metastatic
tumor in the arm that underwent complete remission after radiotherapy.Clin Case Rep . 2020;8(12):3542-3544. doi:10.1002/ccr3.3119.
4. Lok BH, Jiang G, Gutiontov S, et al. Palliative head and neck
radiotherapy with the RTOG 8502 regimen for incurable primary or
metastatic cancers. Oral Oncol . 2015;51(10):957-962. doi:10.1016/j.oraloncology.2015.07.011.
5. Toya R, Saito T, Yamaguchi K, et al. Hypofractionated palliative
volumetric modulated arc radiotherapy with the Radiation Oncology Study
Group 8502 “QUAD shot” regimen for incurable head and neck cancer.Radiat Oncol . 2020;15(1):123. doi:10.1186/s13014-020-01548-w.
6. Mirmohammad Sadeghi H, Karimi A, Rahpeima A, Derakhshan S. Salivary
duct carcinoma with late distant brain and cutaneous metastasis: A case
report. Iran J Pathol . 2020;15(3):521-525. doi:10.30699/ijp.2020.103326.2039.
7. Chakari W, Andersen L, Andersen JL. Cutaneous metastases from
salivary duct carcinoma of the submandibular gland. Case Rep
Dermatol . 2017;9(3):254-258. doi:10.1159/000485371.
8. Perez DE, Magrin J, de Almeida OP, Kowalski LP. Multiple cutaneous
metastases from a parotid adenoid cystic carcinoma. Pathol Oncol
Res . 2007;13(2):167-169. doi:10.1007/BF02893495.
9. Arase S, Sanuki N, Matsuura H. Cutaneous metastasis of prostate
carcinoma treated with electron radiotherapy. IJU Case Rep .
2019;2(4):190-192. doi:10.1002/iju5.12078.
10. Spanos W Jr, Guse C, Perez C, Grigsby P, Doggett RL, Poulter C.
Phase II study of multiple daily fractionations in the palliation of
advanced pelvic malignancies: preliminary report of RTOG 8502. Int
J Radiat Oncol Biol Phys . 1989;17(3):659-661. doi:10.1016/0360-3016(89)90120-x.
11. Corry J, Peters LJ, Costa ID, et al. The “QUAD SHOT”—a phase II
study of palliative radiotherapy for incurable head and neck cancer.Radiother Oncol . 2005;77(2):137-142. doi:10.1016/j.radonc.2005.10.008.
12. Kil WJ, Camphausen K, Cho IH. Clinical and radiobiological
consideration of cyclical hypofractionated radiation therapy also known
as QUAD Shot for neglected skin cancer disfiguring the face of a
non-compliant patient who was refusing surgery and protracted radiation
therapy: case report. Radiat Oncol J . 2019;37(2):143-148. doi:10.3857/roj.2019.00248.
13. Brockwell M, Husain M, Verschraegen C, Wu R, Tinoco G. Case report:
the power of immunotherapy in advanced cutaneous squamous cell
carcinoma. Front Oncol . 2022;12:1081118. doi:10.3389/fonc.2022.1081118.
14. Gamez ME, Agarwal M, Hu KS, Lukens JN, Harrison LB. Hypofractionated
palliative radiotherapy with concurrent radiosensitizing chemotherapy
for advanced head and neck cancer using the ”QUAD-SHOT regimen”.Anticancer Res. 2017;37(2):685-691. doi:10.21873/anticanres.11364.
15. Carrascosa LA, Yashar CM, Paris KJ, Larocca RV, Faught SR, Spanos
WJ. Palliation of pelvic and head and neck cancer with paclitaxel and a
novel radiotherapy regimen. J Palliat Med . 2007;10(4):877-881.
doi:10.1089/jpm.2006.0192.